TVRD

Tvardi Therapeutics
$2.54
+$0.03 (+1.2%)Jul 27, 2026
0.5PoorMoatMint rating

MoatMint rates Tvardi Therapeutics (TVRD) 0.5 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 2.7 out of 10.

Key metrics

The numbers that frame TVRD today
Market cap
$23.83M
P/E (TTM)
-1.5
EV / FCF
-0.2
ROIC
-456.5%
Div yield
0%
Debt / equity
0.0
52wk Low
$1.50
52wk High
$43.65

TVRD stock rating

How TVRD scores on quality, value, growth, momentum and financial health
0.5out of 10
Low overallNeutral business, expensive priceTop 95% of ~5,000 US stocks
QualityFair2.7/10
GrowthNeutral4.0/10
MomentumPoor0.7/10
ValuePoor0.1/10
Financial HealthPoor1.0/10

Growth

Revenue and earnings trend for TVRD
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about TVRD
Is Tvardi Therapeutics a good buy?
No. Tvardi Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks weak. That could put pressure on the long-term business case. We think Tvardi Therapeutics is selling at a very high price.
What is the market capitalization of TVRD?
Tvardi Therapeutics's market capitalization is $23.83M.
What is the P/E ratio for TVRD stock?
Tvardi Therapeutics's current P/E ratio is -1.5.
What is the 52-week high for TVRD stock?
The 52-week high for Tvardi Therapeutics is $43.65. The current close of $2.54 is 94.2% below that high.
What is the 52-week low for TVRD stock?
The 52-week low for Tvardi Therapeutics is $1.50. The current close of $2.54 is 69.3% above that low.
Does TVRD stock pay dividends?
Tvardi Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for TVRD?
Tvardi Therapeutics's Debt / Equity ratio is 0.01.